Ropinirole Cotreatment Prevents Perivascular Glial Recruitment in a Rat Model of L-DOPA-Induced Dyskinesia

Dopamine replacement therapy for Parkinson’s disease is achieved using L-DOPA or dopamine D2/3 agonists, such as ropinirole. Here, we compare the effects of L-DOPA and ropinirole, alone or in combination, on patterns of glial and microvascular reactivity in the striatum. Rats with unilateral 6-hydro...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Osama F. Elabi, Elena Espa, Katrine Skovgård, Silvia Fanni, Maria Angela Cenci
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Subjects:	levodopa-induced dyskinesia dopamine agonist neuroinflammation
Online Access:	https://www.mdpi.com/2073-4409/12/14/1859